Polaryx Therapeutics Inc. Common Stock

PLYX | NASDAQ

$1.77

+$0.02 (+1.14%)

Nov 2, 2026, 2:09 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023
Net Income	-8.99M	-30.36M	-3.78M
Depreciation & Amortization	n/a	n/a	n/a
Stock-Based Compensation	n/a	2.4M	3.24M
Other Working Capital	-82K	-220K	421K
Other Non-Cash Items	4.73M	26M	n/a
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	316K	-621K	369K
Operating Cash Flow	-3.94M	-2.57M	-173K
Capital Expenditures	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a
Debt Repayment	n/a	-128K	128K
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a
Financial Cash Flow	4.47M	7.19M	128K
Net Cash Flow	522K	4.62M	-45K
Free Cash Flow	-3.94M	-2.57M	-173K
Adj. Free Cash Flow	-3.94M	-4.97M	-3.41M
Maintenance CapEx	n/a	n/a	n/a
Growth CapEx	n/a	n/a	n/a
Owner Earnings	-3.94M	-2.57M	-173K